 (Boston, MA) is expanding its imaging capabilities for cardiology trials with the addition of  nuclear imaging technology from   

"Key goals in expanding our capabilities with this advanced nuclear imaging functionality are to help customers make earlier safety and efficacy assessments and better decisions about their compounds in order to bring new cardiovascular treatments to patients sooner,” said Kenneth G. Faulkner, PhD, Perceptive's Vice President of Medical Imaging, in a press release.

By incorporating components of Hermes Medical Solutions' 

, Perceptive says it will enhance the electronic processing, review, analysis, reporting, and archiving of images for cardiology trials. 